newsfilter
← Latest News
Business Wire·

Revance Announces Proposed Public Offering of Common Stock

Revance Therapeutics, Inc. (NASDAQ:RVNC) ("Revance" or the "Company") today announced a proposed underwritten public offering of $100 million of its common stock. In addition, the Company expects to grant the